Dr. Eric Anderson
Claim this profileNorth Colorado Medical Center
Studies Tumors
Studies Cancer
10 reported clinical trials
35 drugs studied
Area of expertise
1Tumors
Stage IV
Stage III
HER2 negative
2Cancer
Stage IV
Stage III
HER2 negative
Affiliated Hospitals
Clinical Trials Eric Anderson is currently running
Stem Cell Transplant Conditioning
for SCID
The investigators want to study if lower doses of chemotherapy will help babies with SCID to achieve good immunity with less short and long-term risks of complications after transplantation. This trial identifies babies with types of immune deficiencies that are most likely to succeed with this approach and offers them transplant early in life before they get severe infections or later if their infections are under control. It includes only patients receiving unrelated or mismatched related donor transplants. The study will test if patients receiving transplant using either a low dose busulfan or a medium dose busulfan will have immune recovery of both T and B cells, measured by the ability to respond to immunizations after transplant. The exact regimen depends on the subtype of SCID the patient has. Donors used for transplant must be unrelated or half-matched related (haploidentical) donors, and peripheral blood stem cells must be used. To minimize the chance of graft-versus-host disease (GVHD), the stem cells will have most, but not all, of the T cells removed, using a newer, experimental approach of a well-established technology. Once the stem cell transplant is completed, patients will be followed for 3 years. Approximately 9-18 months after the transplant, vaccinations will be administered, and a blood test measuring whether your child's body has responded to the vaccine will be collected.
Recruiting1 award Phase 244 criteria
Hormone + Radiation Therapy
for Prostate Cancer
This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.
Recruiting2 awards Phase 36 criteria
More about Eric Anderson
Clinical Trial Related5 years of experience running clinical trials · Led 10 trials as a Principal Investigator · 5 Active Clinical TrialsTreatments Eric Anderson has experience with
- Radiation Therapy
- Histrelin
- Bicalutamide
- Leuprolide
- Triptorelin
- Goserelin
Breakdown of trials Eric Anderson has run
Tumors
Cancer
Prostate Adenocarcinoma
Breast Cancer
Bladder Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Eric Anderson specialize in?
Eric Anderson focuses on Tumors and Cancer. In particular, much of their work with Tumors has involved Stage IV patients, or patients who are Stage III.
Is Eric Anderson currently recruiting for clinical trials?
Yes, Eric Anderson is currently recruiting for 4 clinical trials in Greeley Colorado. If you're interested in participating, you should apply.
Are there any treatments that Eric Anderson has studied deeply?
Yes, Eric Anderson has studied treatments such as Radiation Therapy, Histrelin, Bicalutamide.
What is the best way to schedule an appointment with Eric Anderson?
Apply for one of the trials that Eric Anderson is conducting.
What is the office address of Eric Anderson?
The office of Eric Anderson is located at: North Colorado Medical Center, Greeley, Colorado 80631 United States. This is the address for their practice at the North Colorado Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.